BIOVIA

Simulations Plus Announces Leadership Appointments Supporting Commitment to Clients and Driving Growth

Retrieved on: 
Wednesday, January 3, 2024

Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced the following leadership changes effective January 3, 2024.

Key Points: 
  • Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced the following leadership changes effective January 3, 2024.
  • “We have a deep bench of talent at Simulations Plus, and I am delighted to recognize the excellent leadership and accomplishments that each person has demonstrated.
  • Mr. Frederick has served as Chief Financial Officer since joining Simulations Plus in December 2020.
  • Dr. Suarez-Sharp joined Simulations Plus over three years ago and has been instrumental in initiating the company’s regulatory support to clients.

Dassault Systèmes, McPhy and Visiativ Team Up to Drive the Green Energy Transition

Retrieved on: 
Tuesday, December 20, 2022

McPhy – a long-time SOLIDWORKS customer – chose to move to a collaborative business platform deployed by the Visiativ team.

Key Points: 
  • McPhy – a long-time SOLIDWORKS customer – chose to move to a collaborative business platform deployed by the Visiativ team.
  • “The Dassault Systèmes 3DEXPERIENCE platform deployed by Visiativ will help us structure our teams and our business.
  • Green hydrogen can be used to decarbonize the industrial sector as an energy carrier or as a raw material for steel production.
  • “The success of this partnership is thanks to the collaboration, mutual trust, and commitment of McPhy, Dassault Systèmes and Visiativ,” said Laurent Fiard, CEO, Visiativ.

Dassault Systèmes, Egis and B4 Partner in Project to Rebuild Cities in Ukraine

Retrieved on: 
Tuesday, December 13, 2022

Dassault Systmes 3DEXPERIENCE platform will support the collaboration and host all the information and analysis gathered by EGIS and B4 experts.

Key Points: 
  • Dassault Systmes 3DEXPERIENCE platform will support the collaboration and host all the information and analysis gathered by EGIS and B4 experts.
  • Today we run 23 projects in Ukraine that aim to rebuild cities and infrastructure.
  • We aim to help local authorities improve cities in Ukraine, and life within them, through this meaningful joint project that will have impacts over the long-term.
  • "Despite the ongoing invasion, Ukraines local authorities are already thinking about the future and planning how to rebuild their cities.

Everest Group Names Medidata a ‘Leader’ and ‘Star Performer’ in Decentralized Clinical Trial Platforms

Retrieved on: 
Tuesday, December 13, 2022

Medidata , a Dassault Systmes company, has been named a Leader and Star Performer in the Decentralized Clinical Trial Platforms PEAK Matrix Assessment 2023 by Everest Group.

Key Points: 
  • Medidata , a Dassault Systmes company, has been named a Leader and Star Performer in the Decentralized Clinical Trial Platforms PEAK Matrix Assessment 2023 by Everest Group.
  • The annual report evaluates decentralized clinical trial (DCT) products from 24 companies based on vision, capability, and market impact.
  • Its solution is highly recognized for governance, security, and compliance by clients, said Chunky Satija, vice president at Everest Group.
  • Recognition from Everest as both a Leader and Star Performer validates the success we have gained with our sponsors and CROs.

Dassault Systèmes and Ecole Normale Supérieure Paris-Saclay Sign MoU to Boost Virtual Twin Knowledge and Know-How

Retrieved on: 
Monday, December 12, 2022

The MoU aims to accelerate sustainable innovation by driving knowledge and know-how on the use of virtual twins in academia and research.

Key Points: 
  • The MoU aims to accelerate sustainable innovation by driving knowledge and know-how on the use of virtual twins in academia and research.
  • Under the MoU, ENS Paris-Saclay will deploy Dassault Systmes 3DEXPERIENCE platform to offer new, innovative learning experiences as part of its university curriculum as well as its continuing education programs.
  • In addition to the deployment, Dassault Systmes and ENS Paris-Saclay will create a virtual twin think tank combining their respective expertise on virtual twins.
  • Dassault Systmes brings value to more than 300,000 customers of all sizes, in all industries, in more than 140 countries.

Medidata Receives Prestigious Innovation Award from Reagan-Udall Foundation for the FDA

Retrieved on: 
Thursday, December 8, 2022

Medidata , a Dassault Systmes company, has been honored by the Reagan-Udall Foundation for the Food and Drug Administration (FDA) with its 2022 Innovation in Regulatory Science Award for Medidata Link.

Key Points: 
  • Medidata , a Dassault Systmes company, has been honored by the Reagan-Udall Foundation for the Food and Drug Administration (FDA) with its 2022 Innovation in Regulatory Science Award for Medidata Link.
  • View the full release here: https://www.businesswire.com/news/home/20221208005087/en/
    Reagan-Udall Foundation for the FDA CEO Susan Winckler (left) Medidata co-CEO Sastry Chilukuri (right) (Photo: Business Wire)
    The award ceremony in Washington, D.C. on December 6 will feature an address by Robert M. Califf, M.D., Commissioner of the FDA and acceptance remarks by Medidata co-CEO Sastry Chilukuri.
  • We are honored to have this advancement recognized by the Reagan-Udall Foundation for the FDA.
  • The Reagan-Udall Foundation embodies the FDAs vision of collaborative innovation to address regulatory science challenges of the 21st century.

Medidata Launches New myMedidata Native App to Expedite Study Start Up and Improve Patient Experience

Retrieved on: 
Tuesday, December 6, 2022

The app will feature all of the myMedidata patient-centric solutions, with an initial focus on eCOA (electronic clinical outcome assessments).

Key Points: 
  • The app will feature all of the myMedidata patient-centric solutions, with an initial focus on eCOA (electronic clinical outcome assessments).
  • Medidata is leveraging its unique insights from sponsors, CROs, sites, and patients to make a meaningful difference in the clinical trial experience.
  • The app is configured using Medidata Designer, a new platform configuration tool, bringing a patient-centered mobile-first workflow builder to the myMedidata app.
  • Designer drastically lowers study build times by employing Medidata and client libraries, including pre-built eCOA instruments, translations, and study configurations.

Dassault Systèmes and Samsung Heavy Industries Cooperate to Establish a Smart Digital Shipyard

Retrieved on: 
Tuesday, November 29, 2022

By introducing model-based systems engineering, Samsung Heavy Industries can design more sophisticated and sustainable vessels requiring more automation, new systems and propulsions, and higher safety and control.

Key Points: 
  • By introducing model-based systems engineering, Samsung Heavy Industries can design more sophisticated and sustainable vessels requiring more automation, new systems and propulsions, and higher safety and control.
  • A smart yard in the shipbuilding industry will also help reduce construction costs and improve the quality of ships, said Jung Nam Lee, DT Director, Samsung Heavy Industries.
  • The cooperation with the Smart SHI team of Samsung Heavy Industries will allow Dassault Systmes to organize a consultative group for digital transformation to define and validate new processes and tools required to achieve the smart yard.
  • Dassault Systmes 3DEXPERIENCE platform-based smart yard will support a unique digital thread integrating various data sources and real-time operations information.

Medidata Patient Insights Leader Alicia Staley Honored by National Coalition for Cancer Survivorship

Retrieved on: 
Tuesday, November 22, 2022

Medidata , a Dassault Systmes company, announced that vice president for Patient Engagement and leader of its Patient Insights Board Alicia Staley has been honored with the Ellen L. Stovall Award for patient advocacy from the National Coalition for Cancer Survivorship (NCCS).

Key Points: 
  • Medidata , a Dassault Systmes company, announced that vice president for Patient Engagement and leader of its Patient Insights Board Alicia Staley has been honored with the Ellen L. Stovall Award for patient advocacy from the National Coalition for Cancer Survivorship (NCCS).
  • View the full release here: https://www.businesswire.com/news/home/20221122005590/en/
    NCCS CEO Shelley Fuld Nasso (left), Medidata vice president for Patient Engagement Alicia Staley Photo: Leslie E. Kossoff/LK Photos
    Alicias influence as a leader reaches a national and, in fact, a global audience.
  • Alicia is one of the most effective community builders, a collaborator, and a facilitator within groups of people seeking to improve care for cancer patients and their families, said Anne Marie Mercurio, a patient advocate who sits on the Medidata Patient Insights Board.
  • Alicia is one of the most respected voices and creative influences in increasing patient engagement in clinical trials, said Anthony Costello, Medidata Patient Cloud CEO.

 OpenFold AI Research Consortium Welcomes 4 New Members: Bayer, Dassault, CHARM Therapeutics and BaseCamp Research

Retrieved on: 
Tuesday, November 22, 2022

Bayer of Leverkusen, Germany, is a global enterprise with core competencies in the life science fields of health care and nutrition.

Key Points: 
  • Bayer of Leverkusen, Germany, is a global enterprise with core competencies in the life science fields of health care and nutrition.
  • Dassault Systmes SE , of Velizy-Villacoublay, France, develops software to create 3D virtual environments for product design, simulation, and manufacturing.
  • CHARM Therapeutics of London is applying 3D deep-learning technology for drug discovery and development.
  • By joining the growing OpenFold community we are excited to strengthen the use of AI in our discovery solution experiences."